2m 2m 2m 2m 2m 2m 2m
TAKEDA PHARM SP ADR (TAK)
NYSE
$17.21+$0.12 (+0.71%)
Price as of Aug 03, 2026 4:04 AM EDT- $54.6BMarket Cap
- 25.53%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
TAKEDA PHARM SP ADR (TAK)
$17.21+$0.12 (+0.71%)
TAK | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $17.09 | ||
Change | -$0.16 (-0.93%) | ||
Open | $17.06 | ||
High | $17.19 | ||
Low | $16.93 | ||
Previous Close | $17.25 | ||
Volume | 4,109,517 | ||
30-Day Average Volume | 3,821,878 | ||
1-Week Change | -0.87% | ||
1-Month Change | 6.61% | ||
1-Year Change | 25.53% | ||
3-Year Change | 26.97% | ||
5-Year Change | 28.64% | ||
Fundamentals | |||
Shares Outstanding | 3.2B | ||
Total Assets | $15.5T | ||
Market Cap | $54.6B | ||
Enterprise Value | -$540.5B | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | N/A | ||
Free Cash Flow | N/A | ||
EBIT | N/A | ||
EBITDA | N/A | ||
Net Working Capital | N/A | ||
EPS | N/A | ||
Enterprise Value/EBITDA | N/A | ||
Enterprise Value/Revenue | N/A | ||
P/B | N/A | ||
P/E | N/A | ||
PEG | N/A | ||
Price/Free Cash Flow | N/A | ||
Price/Operating Cash Flow | N/A | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | 9.02% | ||
Trailing Annual Dividend Yield | 3.69% | ||
Ex-Dividend Date | 03/31/2026 | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue
Annual Dividend Yield